Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Stiff Man: A Case Study in Ankylosing Spondylitis

Charles Radis, DO  |  Issue: July 2017  |  July 12, 2017

AS, unlike rheumatoid arthritis, undeniably goes back thousands of years and afflicts crocodiles, as well as humans.1 Although nearly all rheumatologic conditions are more common in women than men, AS, at least in its most severe forms, occurs more frequently in men.2 We know that the gene coding for the Class 1 MHC molecule, HLA‑B27, is found in more than 90% of Caucasians with AS, and that bacteria in the gastrointestinal tract in some poorly defined way, play a role in the pathogenesis of this disorder.

Rheumatologists have known for decades that patients who are HLA‑B27+ may develop reactive arthritis after GI infections due to Campylobacter, Salmonella, Shigella or Yersinia.3 After exposure, there is a delay of one or two weeks before an explosive large joint polyarthritis occurs (sometimes with axial spine and sacroiliac involvement). The joints themselves are not infected, but are the target of an immunologic storm of pro-inflammatory cytokines. In time, however, reactive arthritis usually resolves.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

But what of AS? How important are bacteria in the pathogenesis of this more insidious and chronic disease? The clues are coming from both basic science and clinical research, but as yet there is not a comprehensive explanation for how we get from the Class I HLA-B27 cell surface molecule to inflamed joints, from a normal spine to a bamboo spine. How do we explain Joshua N or Michael T?

Clarifying the triggers for AS has been elusive, in part due to the complex immunology of the gut. We know that billions of bacteria coexist with us in the gut, but until recently, exactly what they were doing there was a complete mystery. Basic science is beginning to unravel the complex ecology of the gut, which should lead to a clearer understanding of how our own native bacteria affect health.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Scientists can now transfect an attenuated virus (a virus incapable of causing disease), and insert the human HLA-B27 gene into the virus’s genetic code. When the virus is injected into a mouse, copies of the human HLA-B27 markers can subsequently be detected on the cell surface of the mouse’s cells. What happens next to these previously normal mice? They develop diarrhea, inflammation in the bowel and skin, and after a delay of a week or so, inflammation in the joints. This study raises the question: Are the mice’s own native bacteria interacting with the human HLA-B27 gene and triggering arthritis in distant joints?4

Page: 1 2 3 4 5 6 7 8 9 10 11 12 | Single Page
Share: 

Filed under:Axial SpondyloarthritisConditionsOther Rheumatic Conditions Tagged with:Ankylosing SpondylitisArthritisBack paincase reportClinicalDiagnosisManagementMedicationoffice visitpatient carerheumatologistrheumatologyspineTreatment

Related Articles
    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    July 13, 2016

    The mechanistic link between human leukocyte antigen B27 (HLA-B27) and ankylosing spondylitis (AS) is one of the great enigmas in rheumatology. The introduction of biological therapies that target tumor necrosis factor (TNF) or the interleukin (IL) 23/IL-17A axis has had a major impact on the quality of life for many patients with AS, and one…

    Conformational Flexibility in HLA-B27 Provides Clues to Development of Ankylosing Spondylitis

    July 11, 2016

    Understanding how human leukocyte antigen (HLA) class I molecule B27 promotes spondyloarthritis has intrigued researchers for four decades. Although the association between the single gene variant HLA-B27—specifically some of its subtypes—with ankylosing spondylitis (AS) is particularly strong, how HLA-B27 directly influences disease development has not yet been clearly explained, although hypotheses continue to be generated….

    Data Accumulate to Suggest HLA-B27 Status May Drive Axial Phenotype in SpA

    May 20, 2022

    HLA-B27 may be a phenotypic expression of axial spondyloarthritis (SpA), according to a large international study. The study found patients with axial SpA who were positive for HLA-B27 had more severe radiographic damage than those who were negative for HLA-B27, and three quarters of study patients with ankylosis spondyloarthritis were HLA-B27 positive.

    Anatomy Insider / shutterstock.com

    Gut Instinct: Ankylosing Spondylitis & the Microbiome

    October 3, 2019

    CHICAGO—At the 2019 ACR State-of-the-Art Clinical Symposium, an annual gathering featuring talks by key opinion leaders on the most salient topics for practicing rheumatologists and healthcare providers, Jose U. Scher, MD, director of the Microbiome Center for Rheumatology and Autoimmunity at NYU Langone Medical Center, New York City, was the featured speaker. In his remarks,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences